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http://dx.doi.org/10.1016/j.ccr.2013.03.009SUMMARYHere, we report that kinase-dead IKKa knockin mice develop spontaneous lung squamous cell carcinomas
(SCCs) associated with IKKa downregulation and marked pulmonary inflammation. IKKa reduction upregu-
lated the expression of p63, Trim29, and keratin 5 (K5), which serve as diagnostic markers for human lung
SCCs. IKKalowK5+p63hi cell expansion and SCC formation were accompanied by inflammation-associated
deregulation of oncogenes, tumor suppressors, and stem cell regulators. Reintroducing transgenic
K5.IKKa, depleting macrophages, and reconstituting irradiated mutant animals with wild-type bone marrow
(BM) prevented SCCdevelopment, suggesting that BM-derived IKKamutantmacrophages promote the tran-
sition of IKKalowK5+p63hi cells to tumor cells. This mousemodel resembles human lung SCCs, sheds light on
the mechanisms underlying lung malignancy development, and identifies targets for therapy of lung SCCs.INTRODUCTION
Lung cancer is the leading cause of cancer mortality worldwide,
and the 5 year survival rate of patients with non-small cell lung
carcinomas (NSCLCs) remains as low as 15% (Larsen and
Minna, 2011). Therefore, new approaches to detect, cure, and
prevent this devastating disease represent an urgent medical
need. NSCLCs include adenocarcinomas (ADCs), squamous
cell carcinomas (SCCs), and large cell carcinomas. Activating
K-ras mutations have been identified in 10%–30% of human
lung ADCs but in less than 5% of human lung SCCs (DuPage
et al., 2009; Larsen and Minna, 2011). An oncogenic mutation
in K-ras that changes a glycine at codon 12 to aspartic acid
(K-rasG12D) induces spontaneous lung ADCs in mice (JohnsonSignificance
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standing of the pathogenesis, treatment, and prevention of lung
cancer. Lung SCCs are strongly associated with smoking, sug-
gesting that smoking-induced gene damage and inflammation
are crucial for the development of this malignancy (Hecht,
2003; Larsen and Minna, 2011). Although many molecular alter-
ations, such as deregulated epidermal growth factor receptor
(EGFR), PIK3CA, p53, and c-Myc, have been identified in human
lung SCCs (Hammerman et al., 2012; Hecht, 2003), lung SCCs
have not been well recapitulated in animals.
Although K-rasG12D fails to induce spontaneous lung SCCs in
mice, Ji et al. (2007) have shown that 56% of K-rasG12D mice
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Figure 1. Identification of Lung SCCs in IkkaKA/KA Mice
(A) The K at 44 is replaced by A within the IKKa kinase domain in IkkaKA/KA mice.
(B) Western blot shows IKKa levels in WT and IkkaKA/KA lungs. NB, newborn; b-actin, protein-loading control.
(C) Lung SCC incidence in IkkaKA/KA, L-IkkaKA/KA, and K-IkkaKA/KA mice with FVB background. n, mouse numbers.
(D) WT and L-IkkaKA/KA lung weights (mean ± SD of three mice per group). NB, newborn; g, gram. Statistical analysis: *p < 0.05; **p < 0.01; ***p < 0.001
(Student’s test).
(E) The histology of hematoxylin and eosin (H&E)-stained WT lungs and SCCs derived from L-IkkaKA/KA lungs. Arrows indicate SCC foci. Scale bar, 50 mm.
(F) IHC-stained K5, p63, and Ki67 in paraffin sections of WT lungs and L-IkkaKA/KA lung SCCs. Brown, positive staining; blue, nuclear countering staining.
Scale bar, 50 mm.
(legend continued on next page)
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LKB1 loss provide complementary pathways, which lead to
lung SCC development. In human, germ-line mutations in Lkb1
are associated with Peutz-Jeghers syndrome, and the Lkb1mu-
tations have been also identified in a variety of human epithelial
cancers, including lung SCCs (Hearle et al., 2006; Ji et al., 2007).
Interestingly, Lkb1/ mouse embryonic fibroblasts (MEFs) are
resistant to oncogenic Ras-mediated cell proliferation and trans-
formation (Bardeesy et al., 2002), indicating that LKB1 and Ras
cooperate in promoting tumor development in a cell type-spe-
cific manner.
Lung SCCs are derived from keratin 5-positive (K5+) basal
cells of the pseudostratified bronchial epithelium, while ADCs
are derived from the epithelial cells of alveoli (Hackett et al.,
2011; Woodworth et al., 1983). Antibodies against transcription
factor p63, tripartite motif-containing 29 (Trim29) proteins, and
K5 have been used to diagnose human lung SCCs and distin-
guish poorly differentiated lung SCCs from ADCs in the clinic
(Ring et al., 2009). p63, a member of the tumor suppressor p53
family, is required for the formation of the epidermis, other strat-
ified epithelia, and epithelial appendages (Vanbokhoven et al.,
2011). The N-terminal-truncated form of p63 (DNp63) is predom-
inately expressed in the epidermis and is overexpressed in
various epithelial cancers, where it exerts oncogenic activities
(Koster et al., 2007; Melino, 2011). In addition, induced bright-
p63/K5+ lung epithelial cells can give rise to alveoli, suggesting
that the bright-p63/K5+ cells are adult stem cells in the lungs (Ku-
mar et al., 2011). Overexpressed Trim29 has been reported in
human lung, bladder, colon, ovarian, endometrial, and gastric
cancers. In these cell types, Trim29 promotes cell proliferation
and inhibits p53 activity (Hatakeyama, 2011). These findings
highlight that increased epithelial cell-specific p63 and Trim29
may also contribute to lung SCC development.
IKKa, one of subunits in the IKK complex (Ghosh and Karin,
2002), is required for the formation of the epidermis during
mouse embryonic development and serves as an innate surveil-
lant that prevents skin tumor development through suppressing
the EGFR- and c-Myc-related pathways in adult mice (Des-
cargues et al., 2008; Hu et al., 1999; Liu et al., 2008). It is known
that K5+ keratinocytes markedly expand in the skin of Ikka/
mice compared to wild-type (WT) mice, Ikka+/ mice have
enhanced susceptibility to chemical carcinogen-induced K5+
SCCs associated with dedifferentiation in the skin, and inducible
K5.CreER-mediated Ikka deletion in keratinocytes causes spon-
taneous skin papillomas and SCCs in Ikka-floxed mice (Hu et al.,
1999, 2001; Liu et al., 2008; Park et al., 2007). These data sug-
gest that K5+ epithelial cells lacking IKKa may be the targets
for SCC development. IKKa downregulation has been reported
in human lung and skin SCCs (Kwak et al., 2011; Marinari
et al., 2008); however, the role that IKKa plays in lung cancer
has not been investigated. In eukaryotic cells, chromatin
consists of packaged chromosomal DNA wound around nucleo-
some cores formed from histones (H). Modifications at these(G) H&E-stained and K5-, p63-, and Ki67 IHC-stained mouse lung ADC induc
Scale bar, 50 mm.
(H) H&E-stained forestomach paraffin sections of WT, K-IkkaKA/KA, and IkkaKA/KA
hyperplasia. Scale bar, 50 mm.
See also Figure S1.histone proteins can alter chromatin structure, which facilitates
or blocks transcription factor access to DNA, thereby regulating
gene transcription without changing gene codes. Epigenetics
plays a major role in embryonic development. Notably, the
bivalent modifications of H3 lysine 4 trimethylation (H3K4me3),
a positive transcription mark, and H3K27me3, a negative tran-
scription mark, on the loci of genes regulate stem cell prolifera-
tion and differentiation (Bernstein et al., 2006). Nuclear IKKa
has been shown to regulate the cell cycle checkpoint in keratino-
cytes in an epigenetic manner (Liu et al., 2008; Zhu et al., 2007).
Whether altering the normal epigenetic control of the nuclear
IKKa affects the establishment of tumor cells during carcinogen-
esis remains unknown.
Inflammatory cells are mobile, plastic, and able to produce
many factors (Hanahan andCoussens, 2012). Thus, they orches-
trate complex communications among different types of cells at
pathological sites, regulating the development of various dis-
eases. Chronic inflammation plays a crucial role in tumor
development.
To understand the pathogenesis of lung SCCs, in this study,
we attempt to establish a mouse lung SCC model, which may
recapitulate human lung SCC development, and to identify
crucial events, which may be used to prevent and treat this
lung disease.
RESULTS
IKKa Reduction Is Associated with the Development of
Spontaneous Lung SCCs in Kinase-Dead IKKa Knockin
Mice
We generated kinase-dead IKKa knockin (IkkaK44A/K44A,
IkkaKA/KA) mice, in which the lysine (K) at amino acid 44, an
ATP-binding site, was replaced with alanine (A) (Figure 1A; Zhu
et al., 2007). IkkaKA/KA newborn mice did not display any obvious
abnormalities, indicating that IKKa kinase inactivation does not
affect mouse embryonic development. However, after 3 months
of age, mutant mice with an FVB background displayed severe
skin lesions and developed systemic inflammation (these pheno-
types are not discussed in this study) and the mice began to die
after 6–10 months. Unexpectedly, spontaneous lung tumors
appeared in FVB IkkaKA/KA mice from 4 to 10 months of age.
Despite the fact that IkkaKA/KAmice with severe skin phenotypes
have to be euthanized at early age, tumors were detected in 20%
of the mutant mice. To determine the relationship between IKKa
and lung tumor development, we examined IKKa levels in mouse
lungs. Western blotting showed a strong expression of IKKa in
WT mouse lungs and that IKKa expression was slightly reduced
in elder mice (Figure 1B, top panel). IKKa levels were lower in the
lungs of IkkaKA/KA newborns and markedly decreased in the
lungs of 4-month-old IkkaKA/KA mice (Figure 1B, bottom panel),
indicating that IKKa reduction is associated with lung tumor
development. To determine whether the K44A mutation
may contribute to the reduction of the IKKa protein, we useded by K-rasG12D. Brown, positive staining; blue, nuclear countering staining.
(with SCC in situ; see also Figure S1F) mice at 1.2 years of age. AH, atypical
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IKKa protein degradation compared to WT IKKa (Figure S1A
available online). We previously reported that IKKa RNA levels
were decreased in IkkaKA/KA mice (Balkhi et al., 2012). Thus,
IKKa is downregulated both at the level of messenger RNA
(mRNA) expression and posttranslationally in IkkaKA/KA mice. In
order to keep the IkkaKA/KA mice alive long enough to study
lung cancer development, the skin phenotype of IkkaKA/KA
mice was corrected by expression of WT IKKa complementary
DNA (cDNA) in the epidermis under the control of a truncated lor-
icrin promoter (Lori.IKKa) (Liu et al., 2006; Figure 1C). Although
Lori.IKKa;IkkaKA/KA (L-IkkaKA/KA) mice displayed almost no skin
phenotype, all of 50 L-IkkaKA/KA mice developed spontaneous
lung tumors. Next, we introduced the WT IKKa transgene under
the control of the K5 promoter (Liu et al., 2008), which is ex-
pressed in the basal epidermal keratinocytes and the basal
lung epithelial cells of bronchia, into IkkaKA/KA mice (Figure 1C).
Although K5.IKKa; IkkaKA/KA (K-IkkaKA/KA) mice survived longer
than L-IkkaKA/KA mice, we did not observe lung tumors in all of
30 K-IkkaKA/KA mice at more than 1 year of age. Analysis by
RT-PCR confirmed that Lori.IKKa was expressed in the skin
and that K5.IKKa was expressed in the skin and lungs (Fig-
ure S1B). These results demonstrate that epithelial cell-derived
IKKa prevents lung tumor development.
The weight of L-IkkaKA/KA lungs compared to WT lungs gradu-
ally increased with age (Figure 1D), indicating that lung tumor
development is associated with increased lung size. Most FVB
L-IkkaKA/KA mice were not able to live longer than 7 or 8 months,
because their lung weights continued to increase with age, and
most lung SCCs were observed in L-IkkaKA/KA mice at 4–
6 months of age. Lung tumor foci with the typical SCC features
of keratin pearls and squamous cellular morphology were
observed on the mutant lung surface and interior (Figures 1E
and S1C). Similar to human lung SCCs (Hackett et al., 2011),
lung tumors in L-IkkaKA/KA mice expressed K5, p63, and Ki67
(Figures 1F and S1D), indicating that the spontaneous tumors
in L-IkkaKA/KA (IkkaKA/KA) mice are SCCs. K-rasG12D-induced
lung ADCs were negative for K5 and p63 immunostaining but
showed increased Ki67-positive cells (Figures 1G, S1D, and
S1E). We did not observe lung SCC metastases in L-IkkaKA/KA
mice. It was also reported that metastases from lung ADCs but
not from SCCs were seen in K-rasG12D;Lkb1/ mice (Ji et al.,
2007). In addition, IkkaKA/KA mice lack lymph nodes (Balkhi
et al., 2012). Whether these conditions affect lung SCCmetasta-
ses remains to be investigated in the future.
To determine whether IKKa reduction is associated with squa-
mous cell hyperproliferation and malignant development in the
stratified epithelium of IkkaKA/KA mice, we histologically exam-
ined the forestomach, esophagus, and skin in BL6 L-IkkaKA/KA
mice. All of the 16 IkkaKA/KA mice at 5 months–1.2 years of age
developed atypical squamous hyperplasia in the forestomach,
and two of three IkkaKA/KA mice at 1.2 years of age developed
forestomach SCCs in situ (Figures 1H and S1F). Reintroduced
K5.IKKa rescued the forestomach phenotype in K-IkkaKA/KA
mice. We observed esophageal hyperplasia in all three BL6
IkkaKA/KA mice at 1.2 years of age, but we observed no esopha-
geal phenotypes in all four IkkaKA/KA mice at 5–7 months of
age (Figure S1G). Furthermore, approximately 24% of 25 BL6
IkkaKA/KA mice at 5–10 months of age developed skin SCCs530 Cancer Cell 23, 527–540, April 15, 2013 ª2013 Elsevier Inc.and all IkkaKA/KA mice at more than 3 months of age developed
epidermal keratinocyte hyperproliferation (Figure S1H; data not
shown). Collectively, these results showed a good correlation
between the development of SCC and squamous hyperplasia
and increased IkkaKA/KAmouse age. Thus, the squamous cell hy-
perproliferation and malignancies are associated with IKKa
reduction.
Specific Molecular Alterations in the Lungs and Lung
SCCs of L-IkkaKA/KA Mice and Similar Molecular
Changes in Human and Mouse Lung SCCs
Because K-rasG12D induces lung ADCs in mice (DuPage et al.,
2009), we sequenced K-, H-, and N-ras cDNA isolated from
mouse lung SCCs and found only a low number of random mu-
tations and insertions and no activating mutations in K-, H-, and
N-ras (Figure S2A). Using western blot and quantitative real-time
PCR (qPCR), we found increases in the stem cell regulators
Nanog, Oct3/4, and c-Myc, and small G protein Rhov/Chp
(Cdc42 homologous protein) (Aspenstro¨m et al., 2007) and de-
creases in the tumor suppressors p53 and Rb in lung SCCs
but not in adjacent lung tissues (Figures 2A and 2B). Similarly
to human (Ji et al., 2007; Ring et al., 2009), the levels of insulin
growth factor 1, cyclin-dependent kinase 1 (CDK1), Trim29,
and p63, and the activities of EGFR, extracellular signal-regu-
lated kinase (ERK), and p38 were elevated in L-IkkaKA/KA lungs
and were dramatically increased in lung SCCs compared
to WT lungs, while LKB1 levels were significantly decreased in
L-IkkaKA/KA lung SCCs compared to WT lungs. In addition,
IkBa, an inhibitor of nuclear factor kB (NF-kB) (Ghosh and Karin,
2002), and IKKa levels were reduced, and c-ros-1 receptor tyro-
sine kinase (ROS1), a pro-oncogene receptor tyrosine kinase (Ri-
kova et al., 2007; Takeuchi et al., 2012), was increased to a
similar extent in both L-IkkaKA/KA lungs and SCCs compared to
WT lungs, suggesting that the alterations in IKKa, IkBa, and
ROS1 levels are ubiquitous rather than epithelial cell-specific in
L-IkkaKA/KA mice (Figures 2A and 2B). Because both Trim29
and p63 are specifically expressed in human lung SCCs, we
examined their protein levels and found that Trim29 and
DNp63 levels were increased in L-IkkaKA/KA lungs and further
increased in lung SCCs compared to WT lungs (Figure 2C). To
determine NF-kB activity, we examined the nuclear p65 levels
in the lungs of WT and L-IkkaKA/KA at 4, 16, and 20 weeks of
age after depleting CD45+ cells and found elevated nuclear
p65 levels in L-IkkaKA/KA lungs with increasing age compared
to WT lungs (Figure 2D). We also observed increased p65 levels
in the lungs of 16- and 20-week-old L-IkkaKA/KA mice compared
to WT using immunohistochemistry (data not shown). Increased
nuclear p65 and p50 were detected in a L-IkkaKA/KA lung SCC
cell line (KALLU) compared to a WT lung epithelial cell line M2C
(Padilla-Nash et al., 2012) following tumor necrosis factor (TNF)
stimulation, and the IKKa level was lower in KALLU than in M2C
cells (Figures 2E and 2F), suggesting that the canonical NF-kB
activity was increased in IKKa-deficient lung SCC cells. Collec-
tively, we identified multiple molecular alterations that can be
classified into three groups: (1) specifically deregulated in
SCCs; (2) deregulated prior to tumor formation; and (3) ubiqui-
tously deregulated in L-IkkaKA/KA mice.
To compare the similarity of molecular alterations between
mouse and human lung SCCs, we examined alterations in
Figure 2. Molecular Alterations in L-IkkaKA/KA Lungs and Lung SCCs
(A) Western blot shows indicated protein levels in WT lungs, L-IkkaKA/KA lung SCCs, and SCC-adjacent lung tissues (L-IkkaKA/KA lungs). b-actin, protein-loading
control.
(B)qPCRshows theexpression levels (fold)of indicatedgenes (mean±SDof threeor fourmicepergroup).Eachcolumnrepresentsan individual sample thatwas tested
three times.WT and L-IkkaKA/KA lungs were obtained from 9- to 10-week-oldmice. *p < 0.05; **p < 0.01; ***p < 0.001 (Student’s test). N.S., not statistically significant.
(C) Western blot shows Trim29 and DNp63 levels in WT and L-IkkaKA/KA lungs and lung SCCs. b-actin, protein-loading control.
(D) Western blot shows nuclear and cytoplasmic p65 levels in lung cells (CD45) isolated from WT and L-IkkaKA/KA mice at 4, 16, and 20 weeks of age.
(E) Western blot shows IKKa levels in a WT mouse lung epithelial cell line M2C and an L-IkkaKA/KA lung SCC cell line KALLU. b-actin, protein-loading control.
(F) Western blot shows nuclear p65 and p50 levels inM2C and KALLU cells following TNF stimulation (10 ng/ml). H3, histone H3 as nuclear protein loading control;
nuclear, nuclear proteins.
See also Figure S2 and Tables S1 and S2.
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have shown that IKKa is downregulated in a large proportion of
human lung SCCs (Kwak et al., 2011; Marinari et al., 2008). We
confirmed these findings by showing that IKKa levels as
analyzed by western blot were significantly higher in normal
human lungs than in all of the eight human lung SCCs and their
adjacent lung tissues (Figure S2B). Comparative genomic
hybridization revealed c-Myc amplification in three (37%) of the
eight human lung SCCs (Figure S2C). Moreover, we examined
the expression of Trim29 in human lung SCCs compared to
cancer-adjacent lung tissues in human tissue array using immu-
nohistochemical (IHC) staining (Figure S2D). Twenty-four (49%)
of forty-nine human SCCs strongly expressed Trim29 versus
0 (0%) of 50 in cancer-adjacent lung tissues. Four (8%) of
forty-nine human SCCs weakly expressed Trim29 versus 25
(50%) of 50 cancer-adjacent lung tissues. A moderate level of
Trim29 immunostaining was detected in 21 (43%) of 49 human
SCCs and 25 (50%) of 50 cancer-adjacent lung tissues. In addi-
tion to high levels of Trim29 in human and mouse lung SCCs, the
localization of Trim29 expression in the cells of human and
mouse SCCs was similar (Figures S2E and S2F). These results
demonstrate that human and mouse lung SCCs share similar
molecular changes.
In addition, we sequenced the genes of Sox2, PIK3CA (exons
9 and 20), and DDR2 (exons 4, 7, 12, 13, 14, and 16) in ten lung
SCCs derived from L-IkkaKA/KA mice, because the mutations in
these genes have been reported in human lung SCCs (Hammer-
man et al., 2012). We detected several silent mutations in DDR2
and Sox2 and some small insertions and deletions in the introns
and UTRs ofDDR2 andSox2 but nomutations in PIK3CA (Tables
S1 and S2). Whether these genetic alterations affect the function
of these genes remains to be elucidated in the future.
IKKaSuppresses theExpression ofDNp63andTrim29 in
an Epigenetic Manner
Although DNp63 levels were increased in L-IkkaKA/KA lungs
compared to WT, the levels were still lower compared to SCCs
(Figure 2C). The tumor cells represent the majority of cells in
SCCs, whereas the cells in WT and L-IkkaKA/KA lungs are a
mixture of epithelial and other cells. Thus, it is possible that
the p63 level was already elevated in the K5+ epithelial cells in
L-IkkaKA/KA lungs. To test this hypothesis, we compared the in-
tensity of DNp63 and K5 in WT and L-IkkaKA/KA lungs and lung
SCCs using immunofluorescent (IF) staining with anti-DNp63
and anti-K5 antibodies. DNp63 levels were specifically elevated
in the K5+ cells of L-IkkaKA/KA lungs compared to WT, and the
K5+p63hi cells expanded with the formation of lung SCCs (Fig-
ure 3A). The IF-stained DNp63 levels were very weak in WT
lungs, which is consistent with the results shown in Figures 2B
and 2C. Also, Kumar et al. (2011) reported that p63 was unde-
tectable in the lungs of WT mice using IF staining. The intensity
of K5 was also elevated in the epithelial cells of L-IkkaKA/KA lungs
compared to WT (Figure 3A).
We further investigatedwhether IKKa regulates the expression
of Trim29 and DNp63 at the transcriptional level, because mRNA
levels of Trim29 and p63 were increased in L-IkkaKA/KA lungs and
SCCs compared to WT lungs (Figure 2B). Using the chromatin
immunoprecipitation (ChIP) assay with an anti-IKKa antibody,
we detected IKKa binding to the promoter regions of Trim29532 Cancer Cell 23, 527–540, April 15, 2013 ª2013 Elsevier Inc.and p63 genes, which was associated with high levels of
H3K27me3, a negative transcription modifier, and low levels of
H3K4me3, a positive transcription modifier, in WT MEFs;
conversely, in IkkaKA/KA and Ikka/ MEFs and KALLU lung
SCC cells, increased H3K4me3 levels and reduced H3K27me3
levels were associated with the Trim29 and p63 loci (Figure 3B).
The mRNA levels of Trim29 and DNp63 were higher in IkkaKA/KA,
Ikka/, and KALLU cells than inWT cells (Figure 3C). Reintroduc-
ing IKKa decreased H3K4me3 levels and increased H3K27me3
levels on Trim29 and p63 loci and repressed the expression of
Trim29 and p63 in IkkaKA/KA, Ikka/, and KALLU cells (Figures
3B and 3C). Although IkkaKA/KA MEFs maintained a low level of
IKKa, we found that the nuclear kinase-dead IKKa (KA) level
was reduced compared toWT IKKawhenWT IKKa and IKKa-KA
were transfected into cells (data not shown). Thus, the expres-
sion levels of Trim29 and DNp63 were comparable in IkkaKA/KA
and Ikka/ MEFs. These results suggest that IKKa regulates
the expression of both Trim29 and DNp63 at the transcription
level by modifying the chromatin structure of Trim29 and p63
in an epigenetic manner. Furthermore, re-expressed IKKa was
found to repress KALLU cell proliferation compared to the control
vector (Figure 3D). Thus, IKKa also inhibited lung epithelial cell
proliferation. IHC staining further showed strongly stained nu-
clear IKKa in the bronchial epithelial cells of WTmice (Figure 3E),
which supports the result that IKKa suppressed the expression
of DNp63 and Trim29 in the nucleus.
Moreover, we examined the relationship between IKKa and
the expression of p63 and Trim29 in a WT human bronchial
epithelial cell line HBEC (Xi et al., 2010) and a human lung SCC
cell line SW-900. Western blot showed a higher IKKa level in
HBEC cells than in SW-900 cells (Figure 3F). The expression
levels of DNp63 and Trim29 were higher in SW-900 cells than
in HBEC cells, and reintroducing IKKa repressed the expression
of DNp63 and Trim29 in SW-900 cells (Figure 3G). ChIP analysis
showed higher H3K4me3 levels and lower H3K27me3 levels on
p63 and Trim29 loci in SW-900 SCC cells compared to HBEC
cells (Figure 3H). Reintroducing IKKa reversed H3K4me3 and
H3K27me3 levels on p63 and Trim29 genes and decreased the
expression levels of p63 and Trim29 in SW-900 SCC cells (Fig-
ures 3G and 3H). Together, these results indicated a similar reg-
ulatory mechanism by which IKKa regulates p63 and Trim29
expression in human and mouse lung epithelial cells.
Excessive Inflammatory Cells, Cytokines,
and Chemokines Are Present in the Lungs
of L-IkkaKA/KA Mice
To evaluate the effect of the inflammatory microenvironment on
lung tumorigenesis, we examined leukocyte infiltration and
expression of cytokines and chemokines. We found significantly
increased absolute numbers of CD4+ cells and macrophages
(F4/80+) and moderately increased CD8+ cells and neutrophils
(Ly6G+/CD11b+) in the lungs of L-IkkaKA/KA mice compared to
WT mice at 4 and 16 weeks of age (Figure 4A). B cells did not
significantly increase (data not shown), which is consistent with
previous results (Balkhi et al., 2012). Significantly increased
expression (qPCR analysis) of tumor necrosis factor-a, inter-
leukin (IL)-1b, IL-6, IL-4, IL-13, IL-10, chemokine (C-C motif)
ligand 2 (CCL2), chemokine (C-X-C motif) ligand 5, CCL11, and
CCL8 was observed in L-IkkaKA/KA lungs compared to WT
Figure 3. IKKa Regulates Trim29 and p63
Expression in an Epigenetic Manner
(A) Immunofluorescent staining shows K5 (green)
and DNp63 (red) in WT lungs, L-IkkaKA/KA lungs,
and L-IkkaKA/KA lung SCCs. Blue color, DAPI for
nuclear staining; arrows indicate DNp63 staining.
Scale bar, 50 mm.
(B) ChIP assay was performed with indicated
antibodies (Abs) and PCR with Trim29 and
p63 primers in WT, IkkaKA/KA, Ikka/ MEFs, and
a cell line KALLU from L-IkkaKA/KA lung SCCs.
Mock, immunoglobulin G (IgG) as negative
controls; +IKKa, reintroducing IKKa into cells; H3,
control for ChIP assay.
(C) RT-PCR with DNp63 and Trim29 primers
from indicated cells. +IKKa, reintroducing IKKa
into cells.
(D) The proliferation of KALLU cells was examined
at 2, 24, 48, and 72 hr following transfection with
IKKa vector or control vector, using the kit of
CellTiter 96 AQueous One Solution Cell Proliferation
Assay (Promega) and mean ± SD of four samples
per group.
(E) IHC staining with an anti-IKKa antibody shows
strong nuclear IKKa in the cells of bronchial
epithelium of adult WTmice. The area in the box of
the middle panel was amplified at the top panel.
Brown, positive staining; arrows, bronchial
epithelium; blue, nuclear counterstaining; NC,
negative control. Scale bar, 50 mm.
(F) Western blotting shows IKKa levels in a WT
human lung cell line HBEC and a human lung SCC
cell line SW-900. b-actin, protein-loading control.
(G) Left panel: RT-PCR with DNp63 and Trim29
primers from indicated cells. +IKKa, reintroducing
IKKa into cells. Right panel: the comparison of
mRNA levels of DNp63 and Trim29 in HBEC
and SW-900 cells (mean ± SD of three samples
per group). *p < 0.05; **p < 0.01; ***p < 0.01
(Student’s test).
(H) ChIP assay was performed with indicated Abs
and PCR with Trim29 and p63 primers in a normal
human lung cell line and two human lung SCC
cell lines. Mock, IgG as negative controls; +IKKa,
reintroducing IKKa into cells; H3, control for
ChIP assay.
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IKKa Prevents Lung Cancer Development(Figure 4B; Table S3). IF staining showed extensive macrophage
infiltration into SCCs and elevated expression of inducible
nitric oxide synthase (iNOS) (Lechner et al., 2005) in L-IkkaKA/KA
macrophages (Figures 4C and 4D). These results showed
that marked inflammation and oxidants were present in
L-IkkaKA/KA lungs.
To determinewhether increased numbers ofmacrophages are
present in human lung SCCs, we used IHC staining with an
anti-CD68 antibody to examine macrophages in a human array
containing 32 human lung SCCs with their proximal adjacent
lung tissues and distal adjacent lung tissues and found increasedCancer Cell 23, 527–5macrophages in lung SCCs and proximal
adjacent lung tissues compared to distal
adjacent lungs, indicating a good correla-
tion between increased macrophages
and lung SCC development (Figures 4Eand 4F), which is consistent with the observation in the lungs
and lung SCCs of L-IkkaKA/KA mice.
Depleting Macrophages Reduces Inflammation and
Epithelial Proliferation and Prevents Lung SCC
Development
To determine whether inflammation regulates lung SCC devel-
opment, we depleted macrophages in 7-week-old L-IkkaKA/KA
mice by injection of clodronate-loaded liposomes, which induce
macrophage apoptosis (Jenkins et al., 2011). A single treatment
significantly reduced macrophages in treated L-IkkaKA/KA lungs40, April 15, 2013 ª2013 Elsevier Inc. 533
Figure 4. Marked Inflammation in the Lungs of L-IkkaKA/KA Mice
(A) The comparison of indicated leukocytes in the lungs ofWT and L-IkkaKA/KAmice at 4 and 16weeks of age examinedwith flow cytometry analysis (mean ± SDof
four samples per group). *p < 0.05; **p < 0.01; ***p < 0.001.
(B) The expression levels (fold changes) of various cytokines and chemokines in the lungs of L-IkkaKA/KAmice at 4 weeks of agewere compared toWT lungs using
qPCR. The fold changes were calculated with delta-delta cycle threshold methods (mean ± SD of four samples per group). n.s., not statistically significant.
(C) Macrophages, lung SCCs, and WT lungs were immunofluorescently stained with anti-F4/80 (red for macrophages) and anti-K5 (green for epithelial cells)
antibodies. Blue, DAPI for nuclear staining. Scale bar, 50 mm.
(D) The expression of iNOS (red) in macrophages (green) in the lungs of WT and L-IkkaKA/KAmice at 16 weeks of age detected using immunofluorescent staining.
Blue, DAPI for nuclear staining. Scale bar, 50 mm.
(legend continued on next page)
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IKKa Prevents Lung Cancer Developmentcompared to untreated L-IkkaKA/KA lungs (Figure 5A). After
3 months of liposome treatment, the weights of L-IkkaKA/KA
lungs were significantly reduced in comparison to untreated
L-IkkaKA/KA lungs (Figure 5B, right and left panels). The macro-
phage deletion also decreased Trim29 and DNp63 levels,
p38 activity, and DNA damage that was indicated by 8-hydrox-
ydeoxyguanosine (Yang et al., 2009) in treated L-IkkaKA/KA
lungs (Figures 5C and 5D). Using histological examination,
we did not detect lung SCCs in any of the six liposome-treated
L-IkkaKA/KA mice.
We analyzed the effect of macrophage depletion on
global gene expression by comparing gene expression
profiles of L-IkkaKA/KA versus WT lungs and liposome-treated
L-IkkaKA/KA versus WT lungs (Figures 5E and S3A); the full
gene names are reported in Table S4. K6 and K16, which are
highly expressed in hyperproliferative squamous epithelial cells
and SCCs (Hackett et al., 2011), as well as K14, K5, and other
keratins, were highly expressed in L-IkkaKA/KA lungs compared
to WT. Macrophage depletion dramatically reduced the ex-
pression of these keratins (Figure 5E, left panel). Macrophage
depletion also repressed the expression of cell cycle regulators,
metalloproteinases, a disintegrin and metalloproteinases,
growth factors, early growth response genes, cytokines,
and chemokines, and altered the expression of oxidases in
L-IkkaKA/KA lungs (Figures 5E, middle and right panels, and
S3A). Although the clodronate-loaded liposome treatment
reduced macrophages and prevented lung SCCs, we observed
infiltrating lymphocytes in treated L-IkkaKA/KA lungs (Figure S3B).
These results indicate that the excessive macrophages
increased inflammation, epithelial cell proliferation, DNA dam-
age, and activities of many pathways that may contribute to
lung carcinogenesis in L-IkkaKA/KA mice; in contrast, macro-
phage reduction reverses these abnormal responses.
Because K-rasG12D;Lkb1/ mice developed mixed lung
SCCs and ADCs (Ji et al., 2007) and LKB1 downregulation
was found in L-IkkaKA/KA lung SCCs, we examined whether
increased numbers of macrophages were present in the lungs
of K-rasG12D;Lkb1/ mice. The IHC staining showed signifi-
cantly more macrophages in K-rasG12D;Lkb1/ lungs than in
WT lungs but more macrophages in L-IkkaKA/KA lungs than in
K-rasG12D;Lkb1/ lungs (Figures 5F and S3C). These results
demonstrated the presence of increased macrophages in the
lung SCCs derived from L-IkkaKA/KAmice andK-rasG12D;Lkb1/
mice, as well as in human lung SCCs.
L-IkkaKA/KA Bone Marrow Reconstitutes Lung SCCs
in Irradiated L-IkkaKA/KA Mice
To investigate the effects of bone marrow (BM)-derived
macrophages from WT and L-IkkaKA/KA mice on lung SCC
development, we performed BM transplant experiments
by intravenously injecting either L-IkkaKA/KA BM into irradiated
L-IkkaKA/KA and WT mice or WT BM into irradiated L-IkkaKA/KA
mice (Figure S4A). The irradiated WT mice receiving WT BM(E) Comparison of IHC-stained CD68+ cell counts in each tissue of the human arr
p value was examined by Student’s test.
(F) One representative case [see (E)] was shown, and the region in the box was am
nuclear counterstaining; -L, lung tissue. Scale bar, 50 mm.
See also Table S3.were similar to WT mice (data not shown). At 3 months after
the BM injection, all of the ten irradiated L-IkkaKA/KA mice
receiving L-IkkaKA/KA BM had enlarged lungs infiltrated with
many macrophages and lymphocytes and developed lung
SCCs; all of the seven irradiated WT mice receiving L-IkkaKA/KA
BM were SCC-free, and their lungs were infiltrated with a few
macrophages and lymphocytes (Figures 6A–6C and S4B). Six
out of seven irradiated L-IkkaKA/KA mice receiving WT BM were
SCC-free; their lungs, which were infiltrated with many lympho-
cytes but reduced macrophages, were smaller than the lungs of
L-IkkaKA/KA mice receiving L-IkkaKA/KA BM but larger than the
lungs of WT mice receiving L-IkkaKA/KA BM (Figures 6A–6C and
S4B). However, one out of seven irradiated L-IkkaKA/KA mice
receiving WT BM developed a very large lung SCC (Figure S4B).
Because we performed BM transplant experiments in mice at 4
or 5 weeks of age and increased pulmonary inflammation was
already observed in the lungs of 4-week-old L-IkkaKA/KA mice
(Figure 4A), it is possible that the development of this tumor
began prior to BM transfer. These results further showed that
L-IkkaKA/KA-derived macrophages are associated with lung
SCC development.
DISCUSSION
IKKa Downregulation Is Associated with Lung
Enlargement and Lung SCC Development
In this study, we showed that the lungs of L-IkkaKA/KA newborn
mice were relatively normal. The K44A mutation in IKKa destabi-
lized the protein. With increasing age and decreasing IKKa
levels, the lungs became enlarged and lung SCCs occurred in
L-IkkaKA/KA mice. Reintroducing transgenic K5.IKKa prevented
lung enlargement and tumorigenesis, and re-expressing WT
IKKa repressed the proliferation of KALLU lung SCC cells,
suggesting that IKKa is important for the tumor initiation and
maintenance. The elevated activities of EGFR/ERK, cell cycle
regulators, and growth factors may largely contribute to cell
proliferation in the lungs of L-IkkaKA/KA mice. We previously
reported that IKKa loss promotes keratinocyte proliferation and
induces spontaneous skin SCCs (Liu et al., 2008). In the current
study of IkkaKA/KAmice, we found squamous cell hyperprolifera-
tion and SCCs in the forestomach, esophagus, and skin, which
were associated with IKKa reduction. Again, reintroducing
K5.IKKa rescued these phenotypes. These findings demonstrate
that IKKa is required for maintaining the normal function of squa-
mous cells in multiple epithelial organs.
Furthermore, we found significant downregulation of LKB1, a
tumor suppressor, in L-IkkaKA/KA lung SCCs and adjacent lung
tissues compared to WT lungs. It is known that Lkb1 deletion
promotes SCC development in both the lungs and skin (Guru-
murthy et al., 2008; Ji et al., 2007). Lkb1/ knockout mice
died at midgestation with vascular and neural tube defects (Yli-
korkala et al., 2001). Thus, the role of LKB1 in the formation of
stratified epithelial organs is unclear. K14.Cre-mediated Lkb1ay slide (LC991) among three groups (mean ± SD of 32 tissues per group). The
plified in the left panel, indicated by lines. Brown, CD68 positive staining; blue,
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Figure 5. Depletion of Macrophages Prevents Lung SCC Development
(A) Flow cytometry analysis shows the number of macrophages (F4/80) in the lungs of WT, L-IkkaKA/KA, and liposome-treated (Lips-, one treatment)
L-IkkaKA/KA mice.
(B) Left panel: the lungs (g, gram) of L-IkkaKA/KAmice after 3 months of treatment and untreated L-IkkaKA/KAmice. Right panel: the comparison of the lung weights
of treated L-IkkaKA/KA, untreated L-IkkaKA/KA, and WT mice (mean ± SD of three or four mice per group).
(C) Trim29, DNp63, p38, and p-p38 levels in WT, L-IkkaKA/KA, and Lips-L-IkkaKA/KA lungs detected using western blotting. b-actin, protein-loading control.
(D) The IHC-stained 8-hydroxydeoxyguanosine in WT, L-IkkaKA/KA, and Lips-L-IkkaKA/KA lungs. Brown, positive staining. Scale bar, 50 mm.
(E) The comparison of the gene expression profiles (fold) of L-IkkaKA/KA versus WT (red bars) and Lips-L-IkkaKA/KA versusWT lungs (green bars) using microarray.
(F) H&E- or F4/80-IHC-stained lungs of WT, K-rasG12D;Lkb1/, and L-IkkaKA/KA mice. Blue, nuclear-countering staining; brown, positive staining. Scale
bar, 50 mm.
See also Figure S3 and Table S4.
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Figure 6. The Effect of BM Cells on Inflam-
mation and SCC Development in the Lungs
of Mice
(A) Left panel: the lung weights (g, gram) of irradi-
ated WT and L-IkkaKA/KA chimeras at 16 weeks of
age (mean ± SD of three mice per group). Right
panel: tumor incidence in indicated irradiated
chimeras. **p < 0.01.
(B) The appearance of indicated mice at 4 months
of age.
(C) H&E staining and IHC-CD3, -F4/80,
and -CD45R staining in the lungs of indicated
irradiated chimera. Brown, positive staining; blue,
nuclear counterstaining. Scale bar, 50 mm.
See also Figure S4.
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promote the development of chemical carcinogen-induced
benign papillomas, but it does enhance malignant skin SCC
development (Gurumurthy et al., 2008), suggesting that LKB1
loss does not provide a selective growth advantage. Interest-
ingly, however, LKB1 loss-associated SCCs showed increased
EGFR and ERK activities; thus, an indirect mechanism may
activate EGFR/ERK pathways, which cooperate with LKB1 defi-
ciency to promote carcinogenesis. Although the mechanism of
how IKKa regulates LKB1 expression in different cell types
remains to be elucidated, the phenotypic similarities and differ-
ences between IKKa and LKB1 suggest that LKB1 reduction
provides an important pathway to promote IKKa deficiency-
associated tumorigenesis.
In this study, IHC staining showed that the majority of IKKa
was located in the nuclei of lung epithelial cells, underscoring
the importance of nuclear IKKa in maintaining the normality
of lung epithelial cells. We found that IKKa deficiency
increased the transcription levels of Trim29 and DNp63
and that reintroduced WT IKKa repressed the expression ofCancer Cell 23, 527–5Trim29 and DNp63 by modifying
H3K4me3 and H3K27me3 levels on the
Trim29 and p63 loci, indicating that
Trim29 and DNp63 are IKKa targets in
the lung epithelial cells. Human lung
SCC cells are K5+ and overexpress p63
and Trim29 (Ring et al., 2009). In mice,
Ikka loss promotes K5+ keratinocyte pro-
liferation (Hu et al., 1999, 2001; Liu et al.,
2008). Here, we observed K5+p63hi cells
in the lungs of L-IkkaKA/KA mice as well
as in lung SCCs but not in WT mice, and
re-expression of IKKa under the K5
promoter prevented lung SCC develop-
ment in IkkaKA/KA mice. We will further
investigate whether IKKalowK5+p63hi
cells have stem cell features and whether
IKKalowK5+p63hi cells serve as tumor-
initiating cells.
In addition to the further changes in
EGFR/ERK activity and Trim29, DNp63,
IGF, CDK1, and LKB1 levels in SCCs,
only lung SCCs, not precancerous lungs,from L-IkkaKA/KA mice showed decreased p53 and Rb and
increased Nanog, Oct3/4, c-Myc, and Rhov traits, which have
also been reported in human lung SCCs (Larsen and Minna,
2011; Yuan et al., 2010). It is known that p53 loss can promote
tumorigenesis by accelerating pluripotent cell generation
induced by stem cell regulators (Utikal et al., 2009). Elevated
small G proteins can regulate the cytoskeleton and cellular
polarity and promote mitogen-activated protein kinase and
EGFR activities, tumor cell proliferation, and abnormal polarity,
resulting in tumor genomic heterogeneity (Iden and Collard,
2008). These combined abnormal properties may be critical for
maintaining the specific oncogenic cell lineage during lung
SCC development in L-IkkaKA/KA mice. Although p53 genetic
alterations are most frequently detected in human lung SCCs
(Hammerman et al., 2012), most human lung SCCs bear multiple
genetic alterations. Mice lacking p53 and Rb or overexpressing
the oncogenes and stem-like genes do not develop sponta-
neous lung SCCs. Therefore, these specificmolecular alterations
in L-IkkaKA/KA lungs and lung SCCs may be important for lung
SCC development.40, April 15, 2013 ª2013 Elsevier Inc. 537
Figure 7. AWorkingModel of Lung SCC Development in L-IkkaKA/KA
Mice
IKKa downregulation dysregulates the expression of multiple oncogenes
and tumor suppressors in K5+ lung epithelial cells. The mutant macrophages
increase inflammatory responses and oxidative stress to promote DNA
damage in IKKamutant K5+ lung epithelial cells, which further dysregulate the
levels of multiple oncogenes, tumor suppressors, and stem cell genes, thereby
promoting the IKKalowK5+p63hi cell transition to tumor cells in L-IkkaKA/KA
lungs. Arrow down (green), downregulation; arrow up (red), upregulation;
crossing two lines, inhibition.
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in L-IkkaKA/KA Mice
Notably, adult L-IkkaKA/KA mice retain a low level of IKKa. Previ-
ously, we showed that Ikka+/ mice were relatively normal but
were haploid insufficient in chemical carcinogen-induced skin
carcinogenesis (Park et al., 2007), suggesting that reduced
IKKa fails to protect skin cells from environmental inducers.
Thus, it is possible that microenvironmental signals may trigger
and accelerate the development of lung malignancy in
L-IkkaKA/KA mice. Most human lung SCC patients have a long
history of smoking, which is known to induce DNA damage
and inflammation and to affect immune functions (Hecht,
2003). Defining these inflammatory inducers may facilitate the
development of immunotherapy for human lung SCCs.
In this study, we found markedly higher infiltration of macro-
phages and lymphocytes and expression of cytokines and
chemokines in L-IkkaKA/KA lungs compared toWT lungs. The pul-
monary inflammation and lung enlargement occurred prior to
SCC formation. Macrophage depletion using liposome treat-
ment significantly reduced lung weights and prevented SCC
formation in L-IkkaKA/KA mice, indicating that increased macro-
phages promote lung SCC development. Although macro-
phages were reduced, infiltrating lymphocytes were still present
in the lungs of treated L-IkkaKA/KA mice, suggesting that the
lymphocytes alone were not sufficient to promote lung tumori-
genesis. The precise functions of lymphocytes in the lung SCC
development in L-IkkaKA/KA mice remain to be further
investigated.
Previously, we demonstrated that kinase-dead IKKa downre-
gulates the expression of Pax5, a B cell regulator, thereby
impairing early B cell development and promoting myeloid-cell
differentiation in IkkaKA/KA BM (Balkhi et al., 2012). It is possible
that increased mutant macrophages may be one of the inducers
for lung SCC development. The BM transfer experiments538 Cancer Cell 23, 527–540, April 15, 2013 ª2013 Elsevier Inc.showed that six of seven irradiated L-IkkaKA/KA mice receiving
WT BM were SCC-free; all irradiated L-IkkaKA/KA mice receiving
L-IkkaKA/KA BM developed lung SCCs. Although we observed
markedly increased lymphocytes in the lungs of both irradiated
L-IkkaKA/KA mice, there were more macrophages in the lungs
of irradiated L-IkkaKA/KA mice receiving L-IkkaKA/KA BM than in
the lungs of irradiated L-IkkaKA/KA mice receiving WT BM.
Together, these results suggest that L-IkkaKA/KA BM, not WT
BM, strongly promotes lung SCC development. In addition, we
observed a good correlation between increased macrophages
and human lung SCCs or/and lungs bearing SCCs and ADCs
inK-rasG12D;Lkb1/mice, although the effect of increasedmac-
rophages on lung tumorigenesis in different systems remains to
be determined in the future.
It is well known that macrophages generate oxidative stresses
that can induce DNA damage (Hanahan and Coussens, 2012).
We observed increased iNOS, a source of oxidative stress,
in L-IkkaKA/KA macrophages and increased DNA damage in
L-IkkaKA/KA lungs compared to WT. These IKKa mutant macro-
phages were surrounding the SCCs as well as infiltrating into
SCCs. Depleting macrophages not only repressed DNp63
and Trim29 expression, K5+ epithelial cell expansion, and
oxidative stress-associated DNA damage, but also prevented
SCCs in the L-IkkaKA/KA lungs. Thus, the inflammation-mediated
DNA damage may facilitate to select and promote the
IKKalowK5+p63hi cell transition to SCC cells by deregulating
tumor suppressors, oncogenic proteins, and stem cell regulators
(Figure 7). In the future, it will be important to precisely define the
critical molecular events in L-IkkaKA/KA macrophages that pro-
mote lung SCC development and the specific signature of the
inflammation-mediated DNA damage in lung SCCs, andwhether
IKKa kinase inactivation plays a role in promoting gene instability
in the lung epithelial cells surrounded by an inflamed microenvi-
ronment. In addition, we found IKKa downregulation in SCC
adjacent lung tissues. Thus, further investigation is needed to
determine whether reduced IKKa contributes to the inflamma-
tory microenvironment.
The results obtained in BM transfer experiments and in those
in which IKKa was re-expressed in K5-expressing cells showed
that the IKKamutant lung epithelium contributed to the develop-
ment of inflammation and SCCs in L-IkkaKA/KA mice. Many
overexpressed factors, such as IL-13 and IL-4, may educate
macrophages in inflamed L-IkkaKA/KA lungs (Biswas and Manto-
vani, 2010). Thus, identifying crucial inflammatory mediators
may help to develop immunotherapy for lung SCCs. IKKa regu-
lates canonical and noncanonical NF-kB signaling pathways
(Sun, 2011), and its activity is different for these NF-kB pathways
in different types of cells, due to specific cell receptors (Balkhi
et al., 2012). Previously, we showed that IKKa loss reduces
IkBa levels and elevates TNF-mediated NF-kB activity in kerati-
nocytes, because the stronger IKKb kinase may replace IKKa in
the IKK complex (Hu et al., 2001; Park et al., 2007). On the other
hand, canonical and noncanonical NF-kB activities are
decreased in the BM B cells of IkkaKA/KA mice (Balkhi et al.,
2012). In this study, we found that the levels of IkBa were
reduced in L-IkkaKA/KA lungs compared to WT. The canonical
NF-kB activity was higher in L-IkkaKA/KA lungs (CD45 cells),
lung SCCs, and L-IkkaKA/KA lung SCC cell line than in WT lungs
and a WT lung epithelial cell line. Some cytokines and
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targets and may help with recruiting leukocytes to the lungs.
Also, increased NF-kB activity can reduce cell apoptosis (Ghosh
and Karin, 2002). Therefore, we will further determine whether
the increased canonical NF-kB pathway contributes to lung
SCC development in L-IkkaKA/KA mice and whether the
NF-kB pathway can be used as a therapeutic target to prevent
and treat lung SCCs.
EXPERIMENTAL PROCEDURES
Animal Experiments, Human Samples, and Microarray Data
All mice used in this study were cared for in accordance with the guidelines of
the Institutional Animal Care and Use Committee (IACUC) of the National
Institutes of Health, and all animal experiments were approved by IACUC
(protocols 08-074, 08-075, 11-051, and 11-052). IkkaKA/KA (Zhu et al., 2007),
Lori.IKKa (Liu et al., 2006), and K5.IKKa (Liu et al., 2011) mice with FVB or
BL6 background were used in this study. Human lung tumors were obtained
from Dr. David Schrump at the Surgery Branch, National Cancer Institute.
All human samples used in this study were approved by National Institutes
of Health Internal Review Board (protocol 06-C-0014), and informed consent
has been obtained from patients. Human normal lung tissue lysates were
obtained from abcam (ab43320, ab42178, and ab42527, Cambridge, MA).
The tissue array (LC991) containing 32 human SCCs with their proximal and
distal adjacent lung tissues was purchased from US Biomax. The human
lung squamous cell carcinoma cell line SW-900 (HTB-59) was purchased
from American Type Culture Collection. Dr. Kwok-Kin Wong provided the
paraffin lung sections of five K-rasG12D;Lkb1/ mice, and this animal experi-
ment was approved by IACUC of Harvard Medical School (protocol 04-094)
(Ji et al., 2007).
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